{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:48:46Z","timestamp":1762210126843,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.farma.2025.03.020","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T15:27:12Z","timestamp":1747841232000},"page":"373-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estandarizaci\u00f3n y caracterizaci\u00f3n de las diluciones administradas por v\u00eda intravenosa en el paciente cr\u00edtico pedi\u00e1trico"],"prefix":"10.1016","volume":"49","author":[{"given":"Laura","family":"Torralba-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Garc\u00eda-Palomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"L\u00f3pez de Abechuco-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Ramos-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Jim\u00e9nez-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Prieto-Galindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Carmen","family":"Lorenzo-Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Aguado-Barroso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2025.03.020_bb0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pedn.2019.11.006","article-title":"The incidence of peripheral intravenous catheter phlebitis and risk factors among pediatric patients","volume":"50","author":"Suliman","year":"2020","journal-title":"J Pediatr Nurs"},{"key":"10.1016\/j.farma.2025.03.020_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2019.103488","article-title":"Incidence of peripheral intravenous catheter failure and complications in paediatric patients: systematic review and meta analysis","volume":"102","author":"Indarwati","year":"2020","journal-title":"Int J Nurs Stud"},{"issue":"8","key":"10.1016\/j.farma.2025.03.020_bb0015","article-title":"Clinically-indicated replacement versus routine replacement of peripheral venous catheters","author":"Webster","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.farma.2025.03.020_bb0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PEC.0000000000001063","article-title":"First-attempt success, longevity, and complication rates of ultrasound-guided peripheral intravenous catheters in children","volume":"34","author":"Vinograd","year":"2018","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"10.1016\/j.farma.2025.03.020_bb0025","article-title":"Prevalence of phlebitis related to the use of peripheral intravenous devices in children","volume":"23","author":"Bitencourt","year":"2018","journal-title":"Cogitare Enferm"},{"issue":"1S","key":"10.1016\/j.farma.2025.03.020_bb0030","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/NAN.0000000000000396","article-title":"Infusion therapy standards of practice","volume":"44","author":"Gorski","year":"2021","journal-title":"J Infus Nurs"},{"issue":"4","key":"10.1016\/j.farma.2025.03.020_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106552","article-title":"Intravenous antimicrobial administration through peripheral venous catheters\u2013establishing risk profiles from an analysis of 5252 devices","volume":"59","author":"Larsen","year":"2022","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.farma.2025.03.020_bb0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/1129729817747532","article-title":"Infiltration and extravasation in pediatric patients: a prevalence study in a children\u2019s hospital","volume":"19","author":"\u00d6zalp Ger\u00e7eker","year":"2018","journal-title":"J Vasc Access"},{"key":"10.1016\/j.farma.2025.03.020_bb0045","series-title":"Programa flebitis zero [Monograf\u00eda en Internet]","article-title":"Prevenci\u00f3n de complicaciones relacionadas con accesos vasculares de inserci\u00f3n perif\u00e9rica","author":"Su\u00e1rez Mier","year":"2019"},{"issue":"3","key":"10.1016\/j.farma.2025.03.020_bb0050","first-page":"216","article-title":"A review of pH and osmolarity","volume":"6","author":"Stranz","year":"2002","journal-title":"Int J Pharm Compd"},{"author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). CIMA","key":"10.1016\/j.farma.2025.03.020_bb0055"},{"author":"Servicio de Farmacia, Hospital Universitario Son Espases","key":"10.1016\/j.farma.2025.03.020_bb0060"},{"year":"2007","series-title":"Pediatric injectable drugs (The Teddy Bear Book)","author":"Phelps","key":"10.1016\/j.farma.2025.03.020_bb0065"},{"author":"UpToDate. Trimethoprim-sulfamethoxazole (co-trimoxazole): drug information [Base de datos en Internet]. Waltham, MA: UpToDate","key":"10.1016\/j.farma.2025.03.020_bb0070"},{"issue":"1","key":"10.1016\/j.farma.2025.03.020_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/NAN.0000000000000202","article-title":"Development of an evidence-based list of noncytotoxic vesicant medications and solutions","volume":"40","author":"Gorski","year":"2017","journal-title":"J Infus Nurs"},{"issue":"5","key":"10.1016\/j.farma.2025.03.020_bb0080","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4212\/cjhp.v64i5.1069","article-title":"Describing intravenous extravasation in children (DIVE Study)","volume":"64","author":"Paquette","year":"2011","journal-title":"Can J Hosp Pharm"},{"issue":"1","key":"10.1016\/j.farma.2025.03.020_bb0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/NAN.0b013e3182798844","article-title":"Reducing risk of harm from extravasation: a 3-tiered evidence-based list of pediatric peripheral intravenous infusates","volume":"36","author":"Clark","year":"2013","journal-title":"J Infus Nurs"},{"issue":"1","key":"10.1016\/j.farma.2025.03.020_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40268-020-00329-w","article-title":"Standardization and chemical characterization of intravenous therapy in adult patients: a step further in medication safety","volume":"21","author":"Manrique-Rodr\u00edguez","year":"2021","journal-title":"Drugs R D"},{"year":"2023","series-title":"Documento de consenso-INCATIV pedi\u00e1trico [Monograf\u00eda en Internet]","author":"Consejo de Enfermer\u00eda de la Comunidad Valencia (CECOVA)","key":"10.1016\/j.farma.2025.03.020_bb0095"},{"year":"2021","series-title":"Gu\u00eda de buenas pr\u00e1cticas: acceso vascular","author":"Asociaci\u00f3n Profesional de Enfermeras de Ontario (RNAO)","key":"10.1016\/j.farma.2025.03.020_bb0100"},{"issue":"3","key":"10.1016\/j.farma.2025.03.020_bb0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.enfi.2021.05.003","article-title":"Identificaci\u00f3n de medicamentos intravenosos potencialmente irritantes","volume":"33","author":"Ballesteros-Pe\u00f1a","year":"2022","journal-title":"Enferm Intensiva"},{"issue":"4","key":"10.1016\/j.farma.2025.03.020_bb0110","first-page":"504","article-title":"Osmotic strength, osmolality, and osmolarity","volume":"37","author":"Deardorff","year":"1980","journal-title":"Am J Hosp Pharm"},{"issue":"2","key":"10.1016\/j.farma.2025.03.020_bb0115","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/AAC.03694-14","article-title":"Influence of vancomycin infusion methods on endothelial cell toxicity","volume":"59","author":"Drouet","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.farma.2025.03.020_bb0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2131\/jts.24.113","article-title":"Experimental infusion phlebitis: tolerance pH of peripheral vein","volume":"24","author":"Kuwahara","year":"1999","journal-title":"J Toxicol Sci"},{"issue":"Suppl 3","key":"10.1016\/j.farma.2025.03.020_bb0125","doi-asserted-by":"crossref","first-page":"S269","DOI":"10.1542\/peds.2019-3474I","article-title":"The Michigan appropriateness guide for intravenous catheters in pediatrics: miniMAGIC","volume":"145","author":"Ullman","year":"2020","journal-title":"Pediatrics"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325000510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325000510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:44:20Z","timestamp":1762209860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634325000510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1130634325000510"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2025.03.020","relation":{},"ISSN":["1130-6343"],"issn-type":[{"type":"print","value":"1130-6343"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estandarizaci\u00f3n y caracterizaci\u00f3n de las diluciones administradas por v\u00eda intravenosa en el paciente cr\u00edtico pedi\u00e1trico","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2025.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H).","name":"copyright","label":"Copyright"}]}}